Publications

• Feasibility and Safety of Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE for Neuroendocrine Tumor in a Patient With Sickle Cell Anemia.
  Clin Nucl Med
  03/03/2025 Authors: Lawal IO; Gbolahan OB; Marcus C; Jones AT; Shaib WL; Muzahir S
• Diuresis During 18F-Flotufolastat (rhPSMA-7.3) PET/CT Improves Recurrence Detection After Prostatectomy: A Prospective Phase II Trial.
  J Nucl Med Volume: 66 Page(s): 230 - 237
  02/03/2025 Authors: Lawal IO; Mushtaq A; Jani AB; Rupji M; Dhere VR; Patel SA; Bilen MA; Patel PR; Sebastian NT; Switchenko JM
• PPV of Bone Uptake of 18F-Flotufolastat: Evaluation Using SPOTLIGHT Study Data.
  AJR Am J Roentgenol Volume: 223 Page(s): e2431698
  11/01/2024 Authors: Schuster DM; Jani AB; Marcus CV; Chau A; Davis P
• Quarter Century PET/Computed Tomography Transformation of Oncology: Neuroendocrine Tumors.
  PET Clin Volume: 19 Page(s): 187 - 196
  04/01/2024 Authors: Marcus C; Muzahir S; Subramaniam RM
• Editorial Comment: FDG PET/CT Has Impact in Chimeric Antigen Receptor T-Cell Therapy Response Assessment and Outcome Prediction.
  AJR Am J Roentgenol Volume: 222 Page(s): e2330703
  03/01/2024 Authors: Marcus C
• Joint EANM/SNMMI/IHPBA procedure guideline for [99mTc]Tc-mebrofenin hepatobiliary scintigraphy SPECT/CT in the quantitative assessment of the future liver remnant function.
  HPB (Oxford) Volume: 25 Page(s): 1131 - 1144
  10/01/2023 Authors: Arntz PJW; Deroose CM; Marcus C; Sturesson C; Panaro F; Erdmann J; Manevska N; Moadel R; de Geus-Oei L-F; Bennink RJ
• 99m Tc-MIBI SPECT/CT Evaluation of a Renal Collision Tumor.
  Clin Nucl Med Volume: 48 Page(s): e390 - e392
  08/01/2023 Authors: Ali AA; Sivathapandi T; Gupta R; Master VA; Marcus C
• Differences in Failure-Free Survival After Salvage Radiotherapy Guided by Conventional Imaging Versus 18F-Fluciclovine PET/CT in Postprostatectomy Patients: A Post Hoc Substratification Analysis of the EMPIRE-1 Trial.
  J Nucl Med Volume: 64 Page(s): 586 - 591
  04/01/2023 Authors: Lawal IO; Jani AB; Adediran OA; Goyal S; Abiodun-Ojo OA; Dhere VR; Marcus CV; Joshi SS; Master VA; Patel PR
• Paragangliomas and Pheochromocytomas: Positron Emission Tomography/Computed Tomography Diagnosis and Therapy.
  PET Clin Volume: 18 Page(s): 233 - 242
  04/01/2023 Authors: Marcus C; Subramaniam RM
• PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0.
  Eur J Nucl Med Mol Imaging Volume: 50 Page(s): 1466 - 1486
  04/01/2023 Authors: Fendler WP; Eiber M; Beheshti M; Bomanji J; Calais J; Ceci F; Cho SY; Fanti S; Giesel FL; Goffin K
• Impact of 18 F-Fluciclovine PET/CT Findings on Failure-Free Survival in Biochemical Recurrence of Prostate Cancer Following Salvage Radiation Therapy.
  Clin Nucl Med Volume: 48 Page(s): e153 - e159
  04/01/2023 Authors: Lawal IO; Marcus C; Schuster DM; Goyal S; Adediran OA; Dhere VR; Joshi SS; Abiodun-Ojo OA; Master VA; Patel PR
• Treatment Response to Lycopene in Recurrent Prostate Cancer Confirmed on 18 F-Fluciclovine PET/CT.
  Clin Nucl Med Volume: 48 Page(s): 361 - 363
  04/01/2023 Authors: Wu C; Marcus C; Baum Y; Kucuk O; Schuster DM
• Diagnostic performance of IQSPECT with high-speed scanning: A preliminary quality control study in obese patients.
  J Nucl Cardiol Volume: 29 Page(s): 3443 - 3449
  12/01/2022 Authors: Werner RA; Martinez RB; Marcus C; Kruse MJ; Sheikhbahaei S; Solnes LB; Higuchi T; Javadi MS; Rowe SP
• 18F-FDG PET/CT for Response Assessment in Lung Cancer.
  Semin Nucl Med Volume: 52 Page(s): 662 - 672
  11/01/2022 Authors: Marcus C; Tajmir SH; Rowe SP; Sheikhbahaei S; Solnes LB
• 18F-Fluciclovine PET/CT: A Potential Imaging Biomarker for the Evaluation of Multiple Myeloma.
  Clin Nucl Med Volume: 47 Page(s): e613 - e615
  09/01/2022 Authors: Marcus C; Schuster DM; Tajmir SH
• Imaging of Cancer Immunotherapy: Response Assessment Methods, Atypical Response Patterns, and Immune-Related Adverse Events, From the AJR Special Series on Imaging of Inflammation.
  AJR Am J Roentgenol Volume: 218 Page(s): 940 - 952
  06/01/2022 Authors: Sheikhbahaei S; Marcus CV; Sadaghiani MS; Rowe SP; Pomper MG; Solnes LB
• PET Imaging of Oral Cavity and Oropharyngeal Cancers.
  PET Clin Volume: 17 Page(s): 223 - 234
  04/01/2022 Authors: Marcus C; Subramaniam RM
• Incidental Spinal Meningioma on an 18F-Fluciclovine PET/CT.
  Clin Nucl Med Volume: 47 Page(s): e313 - e314
  03/01/2022 Authors: Marcus C; Baugnon K; Schuster DM
• Beyond the AJR: FDG PET/CT May Impact Surgical Management of Oral Cavity Squamous Cell Carcinoma Given High NPV for Detection of Neck Nodal Metastases.
  AJR Am J Roentgenol Volume: 218 Page(s): 384
  02/01/2022 Authors: Subramaniam RM; Marcus C
• Constellation of Von Hippel-Lindau Disease-Related Findings on a 68Ga-DOTATATE PET/CT.
  Clin Nucl Med Volume: 46 Page(s): 829 - 831
  10/01/2021 Authors: Marcus C; John PD; Giles M; Sethi I
• PET Imaging for Head and Neck Cancers
  RADIOLOGIC CLINICS OF NORTH AMERICA Volume: 50 Page(s): 773 - 788
  09/01/2021 Authors: Marcus C; Sheikhbahaei S; Shivamurthy VK; Avery G; Subramaniam R
• PET Imaging for Head and Neck Cancers.
  Radiol Clin North Am Volume: 59 Page(s): 773 - 788
  09/01/2021 Authors: Marcus C; Sheikhbahaei S; Shivamurthy VKN; Avey G; Subramaniam RM
• Ring Sclerosis in Prostate Cancer: Circle of Malignancy or Benignity?
  Clin Nucl Med Volume: 46 Page(s): e286 - e289
  05/01/2021 Authors: Marcus C; Baum Y; Abiodun-Ojo OA; Jani AB; Schuster DM
• Furosemide induced forced diuresis does not significantly impact Ga-68 PSMA-11 renal and urinary bladder activity and interpretative confidence
  Volume: 62
  05/01/2021 Authors: Parihar A; Satapathy S; Abiodun-Ojo O; Marcus C; Kumar R; Singh H; Bhattacharya A; Mittal B; Schuster D
• Imaging in Differentiating Cerebral Toxoplasmosis and Primary CNS Lymphoma With Special Focus on FDG PET/CT.
  AJR Am J Roentgenol Volume: 216 Page(s): 157 - 164
  01/01/2021 Authors: Marcus C; Feizi P; Hogg J; Summerfield H; Castellani R; Sriwastava S; Marano GD
• Role of Non-FDG-PET/CT in Head and Neck Cancer.
  Semin Nucl Med Volume: 51 Page(s): 68 - 78
  01/01/2021 Authors: Marcus C; Subramaniam RM
• Clinical utility of 18F-Fluciclovine PET/CT in recurrent prostate cancer with very low (0.3 ng/mL) prostate-specific antigen levels.
  Am J Nucl Med Mol Imaging Volume: 11 Page(s): 406 - 414
  01/01/2021 Authors: Marcus C; Abiodun-Ojo OA; Jani AB; Schuster DM
• Fluorine-18-Labeled Fluciclovine PET/CT in Primary and Biochemical Recurrent Prostate Cancer Management.
  AJR Am J Roentgenol Volume: 215 Page(s): 267 - 276
  08/01/2020 Authors: Marcus C; Butler P; Bagrodia A; Cole S; Subramaniam RM
• Impact of aging on semiquantitative uptake parameters in normal rated clinical baseline [123I]Ioflupane single photon emission computed tomography/computed tomography.
  Nucl Med Commun Volume: 40 Page(s): 1001 - 1004
  10/01/2019 Authors: Werner RA; Lapa C; Sheikhbahaei S; Marcus C; Solnes LB; Du Y; Leal JP; Buck AK; Higuchi T; Rowe SP
• Novel Functional Renal PET Imaging With 18F-FDS in Human Subjects.
  Clin Nucl Med Volume: 44 Page(s): 410 - 411
  05/01/2019 Authors: Werner RA; Ordonez AA; Sanchez-Bautista J; Marcus C; Lapa C; Rowe SP; Pomper MG; Leal JP; Lodge MA; Javadi MS
• 18F-NaF-PET/CT for the detection of bone metastasis in prostate cancer: a meta-analysis of diagnostic accuracy studies.
  Ann Nucl Med Volume: 33 Page(s): 351 - 361
  05/01/2019 Authors: Sheikhbahaei S; Jones KM; Werner RA; Salas-Fragomeni RA; Marcus CV; Higuchi T; Rowe SP; Solnes LB; Javadi MS
• Visual and Semiquantitative Accuracy in Clinical Baseline 123I-Ioflupane SPECT/CT Imaging.
  Clin Nucl Med Volume: 44 Page(s): 1 - 3
  01/01/2019 Authors: Werner RA; Marcus C; Sheikhbahaei S; Solnes LB; Leal JP; Du Y; Rowe SP; Higuchi T; Buck AK; Lapa C
• Adding value to myocardial perfusion SPECT/CT studies that include coronary calcium CT: Detection of incidental pulmonary arterial dilatation.
  Medicine (Baltimore) Volume: 97 Page(s): e11359
  08/01/2018 Authors: Marcus C; Santhanam P; Kruse MJ; Javadi MS; Solnes LB; Rowe SP
• The Impact of Ageing on Dopamine Transporter Imaging
  Volume: 59
  05/01/2018 Authors: Werner R; Marcus C; Sheikhbahaei S; Higuchi T; Solnes L; Rowe S; Buck A; Lapa C; Javadi M
• Incidental pulmonary arterial dilatation and coronary calcifications in patients with hypertension and normal findings on myocardial perfusion technetium-99m sestamibi single-photon emission computed tomography.
  J Clin Hypertens (Greenwich) Volume: 19 Page(s): 1054 - 1055
  10/01/2017 Authors: Santhanam P; Marcus C; Solnes LB; Kral BG; Javadi MS; Rowe SP
• Precision Medicine and PET/Computed Tomography in Melanoma.
  PET Clin Volume: 12 Page(s): 449 - 458
  10/01/2017 Authors: Mena E; Sanli Y; Marcus C; Subramaniam RM
• PET/Computed Tomography and Precision Medicine: Gastric Cancer.
  PET Clin Volume: 12 Page(s): 437 - 447
  10/01/2017 Authors: Marcus C; Subramaniam RM
• Comparative effectiveness: 18F-FDG-PET/CT versus CT for post-treatment follow-up of patients with lung cancer.
  Nucl Med Commun Volume: 38 Page(s): 720 - 725
  08/01/2017 Authors: Sheikhbahaei S; Ahn SJ; Young B; Taghipour M; Marcus C; Subramaniam RM
• Whole-Body 18F-FDG PET and 18F-FDG PET/CT in Patients with Suspected Paraneoplastic Syndrome: A Systematic Review and Meta-Analysis of Diagnostic Accuracy.
  J Nucl Med Volume: 58 Page(s): 1031 - 1036
  07/01/2017 Authors: Sheikhbahaei S; Marcus CV; Fragomeni RS; Rowe SP; Javadi MS; Solnes LB
• Clinical Indications and Impact on Management: Fourth and Subsequent Posttherapy Follow-up 18F-FDG PET/CT Scans in Oncology Patients.
  J Nucl Med Volume: 58 Page(s): 737 - 743
  05/01/2017 Authors: Taghipour M; Marcus C; Sheikhbahaei S; Mena E; Prasad S; Jha AK; Solnes L; Subramaniam RM
• Diagnostic accuracy of 18F-Sodium Fluoride PET or PET/CT for the detection of bone metastasis in patients with breast and prostate cancer compared with other imaging techniques: A meta-analysis
  Volume: 58
  05/01/2017 Authors: Sheikhbahaei S; Jones KM; Salas-Fragomeni RA; Marcus C; Rowe S; Solnes L; Javadi M
• A no-gold-standard framework to evaluate FDG-PET tumor-segmentation methods on the task of measuring prognostic biomarkers for lung-cancer treatment
  Volume: 58
  05/01/2017 Authors: Jha A; Wray R; Marcus C; Subramaniam R; Frey E
• Effect of tumor size on drug delivery to lung tumors
  
  10/03/2016 Authors: Soltani M; Sefidgar M; Bazmara H; Marcus C; Subramaniam RM; Rahmim A
• Therapy Response Assessment and Patient Outcomes in Head and Neck Squamous Cell Carcinoma: FDG PET Hopkins Criteria Versus Residual Neck Node Size and Morphologic Features.
  AJR Am J Roentgenol Volume: 207 Page(s): 641 - 647
  09/01/2016 Authors: Wray R; Sheikhbahaei S; Marcus C; Zan E; Ferraro R; Rahmim A; Subramaniam RM
• JOURNAL CLUB: Value of Quantitative FDG PET/CT Volumetric Biomarkers in Recurrent Colorectal Cancer Patient Survival.
  AJR Am J Roentgenol Volume: 207 Page(s): 257 - 265
  08/01/2016 Authors: Marcus C; Wray R; Taghipour M; Marashdeh W; Ahn SJ; Mena E; Subramaniam RM
• The value of fourth and subsequent post-treatment 18F-FDG PET/CT scans in the management of patients with non-Hodgkin's lymphoma.
  Nucl Med Commun Volume: 37 Page(s): 699 - 704
  07/01/2016 Authors: Taghipour M; Marcus C; Jones S; Sarangi R; Trahan TJ; Subramaniam RM
• 18F-FDG PET/CT: Therapy Response Assessment Interpretation (Hopkins Criteria) and Survival Outcomes in Lung Cancer Patients.
  J Nucl Med Volume: 57 Page(s): 855 - 860
  06/01/2016 Authors: Sheikhbahaei S; Mena E; Marcus C; Wray R; Taghipour M; Subramaniam RM
• A generalized total effective entrapment metric (gTEE) to quantify burden of homogeneous and heterogeneous tumors in PET imaging for enhanced clinical outcome prediction
  
  03/10/2016 Authors: Rahmim A; Schmidtlein CR; Jackson A; Marcus C; Ashrafinia S; Soltani M; Subramaniam RM
• Impact of point spread function reconstruction on quantitative 18F-FDG-PET/CT imaging parameters and inter-reader reproducibility in solid tumors.
  Nucl Med Commun Volume: 37 Page(s): 288 - 296
  03/01/2016 Authors: Sheikhbahaei S; Marcus C; Wray R; Rahmim A; Lodge MA; Subramaniam RM
• Follow-up FDG PET/CT in Patients With Non-Hodgkin Lymphoma: Value to Clinical Assessment and Patient Management.
  Clin Nucl Med Volume: 41 Page(s): e93 - e97
  02/01/2016 Authors: Taghipour M; Marcus C; Nunna P; Subramaniam RM
• A novel metric for quantification of homogeneous and heterogeneous tumors in PET for enhanced clinical outcome prediction.
  Phys Med Biol Volume: 61 Page(s): 227 - 242
  01/07/2016 Authors: Rahmim A; Schmidtlein CR; Jackson A; Sheikhbahaei S; Marcus C; Ashrafinia S; Soltani M; Subramaniam RM
• The value of follow-up FDG-PET/CT in the management and prognosis of patients with HPV-positive oropharyngeal squamous cell carcinoma.
  J Med Imaging Radiat Oncol Volume: 59 Page(s): 681 - 686
  12/01/2015 Authors: Taghipour M; Marcus C; Califano J; Fakhry C; Subramaniam RM
• FDG PET/CT for Management and Assessing Outcomes of Squamous Cell Cancer of the Oral Cavity.
  AJR Am J Roentgenol Volume: 205 Page(s): W150 - W161
  08/01/2015 Authors: Pasha MA; Marcus C; Fakhry C; Kang H; Kiess AP; Subramaniam RM
• (18)F-FDG PET/CT and Melanoma: Staging, Immune Modulation and Mutation-Targeted Therapy Assessment, and Prognosis.
  AJR Am J Roentgenol Volume: 205 Page(s): 259 - 270
  08/01/2015 Authors: Perng P; Marcus C; Subramaniam RM
• F-FDG PET/CT and Colorectal Cancer: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management.
  J Nucl Med Volume: 56 Page(s): 989 - 994
  07/01/2015 Authors: Marcus C; Marashdeh W; Ahn SJ; Taghipour M; Subramaniam RM
• FDG PET/CT in Pancreatic and Hepatobiliary Carcinomas: Value to Patient Management and Patient Outcomes.
  PET Clin Volume: 10 Page(s): 327 - 343
  07/01/2015 Authors: Parikh U; Marcus C; Sarangi R; Taghipour M; Subramaniam RM
• Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas.
  PET Clin Volume: 10 Page(s): 375 - 393
  07/01/2015 Authors: Sheikhbahaei S; Marcus C; Hafezi-Nejad N; Taghipour M; Subramaniam RM
• Fluorodeoxyglucose positron emission tomography/computerized tomography in differentiated thyroid cancer management: Importance of clinical justification and value in predicting survival.
  J Med Imaging Radiat Oncol Volume: 59 Page(s): 281 - 288
  06/01/2015 Authors: Marcus C; Antoniou A; Rahmim A; Ladenson P; Subramaniam RM
• The value of fourth and subsequent post treatment 18-FDG PET/CT scans in the management and survival outcome prediction of patients with lymphoma
  Volume: 56
  05/01/2015 Authors: Taghipour M; Marcus C; Jones S; Sarangi R; Subramaniam R
• Novel quantitative generalized total effective entrapment (gTEE) metric for enhanced clinical outcome prediction: application to PET/CT imaging of pancreatic cancer
  Volume: 56
  05/01/2015 Authors: Rahmim A; Schmidtlein C; Jackson A; Sheikhbahaei S; Marcus C; Ashrafinia S; Subramaniam R
• Follow up FDG PET/CT for Recurrence Detection and Survival Outcome Prediction in Patients with non-Hodgkin lymphoma
  Volume: 56
  05/01/2015 Authors: Taghipour M; Marcus C; Nunna P; Subramaniam R
• FDG PET/CT and colorectal cancer: Value of fourth and subsequent post therapy follow up scans in patient management
  Volume: 56
  05/01/2015 Authors: Marashdeh W; Marcus C; Ahn SJ; Taghipour M; Subramaniam R
• The value of follow up FDG-PET/CT in the management and prognosis of patients with HPV-positive Oropharyngeal Squamous Cell Carcinoma
  Volume: 56
  05/01/2015 Authors: Taghipour M; Marcus C; Subramaniam R
• Prognostic Value of Hopkins Therapy Assessment Criteria: HNSCC with Residual Nodes identified on CT after Definitive Radiotherapy with or without Chemotherapy
  Volume: 56
  05/01/2015 Authors: Wray R; Marcus C; Zan E; Sheikhbahaei S; Parikh U; Ferraro R; Subramaniam R
• Value of Fluorodeoxyglucose PET/Computed Tomography Patient Management and Outcomes in Thyroid Cancer.
  PET Clin Volume: 10 Page(s): 265 - 278
  04/01/2015 Authors: Ciarallo A; Marcus C; Taghipour M; Subramaniam RM
• PET with Fluorodeoxyglucose F 18/Computed Tomography in the Clinical Management and Patient Outcomes of Esophageal Cancer.
  PET Clin Volume: 10 Page(s): 197 - 205
  04/01/2015 Authors: Kwee RM; Marcus C; Sheikhbahaei S; Subramaniam RM
• 18F FDG PET/CT and Head and Neck Cancer: Patient Management and Outcomes.
  PET Clin Volume: 10 Page(s): 125 - 145
  04/01/2015 Authors: Sheikhbahaei S; Marcus C; Subramaniam RM
• 18F-FDG PET/CT and lung cancer: value of fourth and subsequent posttherapy follow-up scans for patient management.
  J Nucl Med Volume: 56 Page(s): 204 - 208
  02/01/2015 Authors: Marcus C; Paidpally V; Antoniou A; Zaheer A; Wahl RL; Subramaniam RM
• Brain FDG PET and the diagnosis of dementia.
  AJR Am J Roentgenol Volume: 204 Page(s): W76 - W85
  01/01/2015 Authors: Shivamurthy VKN; Tahari AK; Marcus C; Subramaniam RM
• Imaging modality utilization trends in patients with stage III-IV oropharyngeal squamous cell carcinoma.
  Am J Nucl Med Mol Imaging Volume: 5 Page(s): 154 - 161
  01/01/2015 Authors: Ichimiya Y; Alluri K; Marcus C; Best S; Chung CH; Subramaniam RM
• FDG PET/CT in the management of colorectal and anal cancers.
  AJR Am J Roentgenol Volume: 203 Page(s): 1109 - 1119
  11/01/2014 Authors: Agarwal A; Marcus C; Xiao J; Nene P; Kachnic LA; Subramaniam RM
• Brain PET in the diagnosis of Alzheimer's disease.
  Clin Nucl Med Volume: 39 Page(s): e413 - e422
  10/01/2014 Authors: Marcus C; Mena E; Subramaniam RM
• Head and neck PET/CT: therapy response interpretation criteria (Hopkins Criteria)-interreader reliability, accuracy, and survival outcomes.
  J Nucl Med Volume: 55 Page(s): 1411 - 1416
  09/01/2014 Authors: Marcus C; Ciarallo A; Tahari AK; Mena E; Koch W; Wahl RL; Kiess AP; Kang H; Subramaniam RM
• FDG PET/CT in the management of nasopharyngeal carcinoma.
  AJR Am J Roentgenol Volume: 203 Page(s): W146 - W157
  08/01/2014 Authors: Mohandas A; Marcus C; Kang H; Truong M-T; Subramaniam RM
• Follow-up or Surveillance (18)F-FDG PET/CT and Survival Outcome in Lung Cancer Patients.
  J Nucl Med Volume: 55 Page(s): 1062 - 1068
  07/01/2014 Authors: Antoniou AJ; Marcus C; Tahari AK; Wahl RL; Subramaniam RM
• PET/CT in the management of thyroid cancers.
  AJR Am J Roentgenol Volume: 202 Page(s): 1316 - 1329
  06/01/2014 Authors: Marcus C; Whitworth PW; Surasi DS; Pai SI; Subramaniam RM
• Single photon emission computed tomography/computed tomography (SPECT/CT) in sentinel lymph node imaging in head and neck cancer
  Volume: 55
  05/01/2014 Authors: Marcus C; Wahl R; Subramaniam R
• Head and neck PET/CT: Therapy response interpretation criteria ('Hopkins criteria')
  Volume: 55
  05/01/2014 Authors: Marcus C; Tahari A; Ciarallo A; Wahl R; Subramaniam R
• The role of FDG PET/CT in the evaluation of patients with T1 and T2 (early stage) head and neck squamous cell carcinoma
  Volume: 55
  05/01/2014 Authors: Marcus C; Wahl R; Subramaniam R